Takeda Pharmaceutical Sees Strong Quarterly Growth

Takeda Pharmaceutical Co (JP:4502) has released an update.

Takeda Pharmaceutical reports a 14.1% increase in revenue and a 6.6% rise in net profit for the quarter ending June 30, 2024, despite a slight drop in operating profit. The company’s core operating profit and core earnings per share (EPS) also saw significant improvements, increasing by 17.1% and 17.3% respectively. Dividend projections remain unchanged with an anticipated total annual payout of 196.00 JPY per share for the fiscal year ending March 31, 2025.

For further insights into JP:4502 stock, check out TipRanks’ Stock Analysis page.